Axonis Therapeutics is a Biotech company based in Boston. It has raised $157M in total funding. Latest round: Series A.
Axonis Therapeutics is a Biotech company based in Boston. Axonis Therapeutics has raised $157M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for Axonis Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, venBio Partners, Sofinnova Investments, MRL Ventures Fund, Perceptive Advisors, Solasta Ventures and 7 others. 13 distinct backers are named across the disclosed rounds.
We update the Axonis Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026